Exeliom Biosciences

Dijon, France · Founded 2016 · Privately Held (backing)

Developer of immunotherapies designed to help harness the therapeutic potential of gut microbiota. Exeliom Biosciences is based in Dijon, France and was founded in 2016. Its last reported valuation was $7.4 million in Dec 2018. It has raised $33.3 million.

Last reported valuation

$7.4M

Oct 2026

Priced at

—

Total raised

$33.3M

Last round

—

How much has Exeliom Biosciences raised?

$33.3Macross 0 recorded rounds

Free account

More of Exeliom Biosciences with a free account

·The complete investor list: 19 names
·Watch Exeliom Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Exeliom Biosciences investors

19 investors are on record for Exeliom Biosciences, including Bpifrance, European Innovation Council, UI Investissement and Elaia Partners.

For fundraisers

Raising for a company like Exeliom Biosciences?

19 investors have backed Exeliom Biosciences.

See all 19 investors →

Frequently asked about Exeliom Biosciences

How much has Exeliom Biosciences raised?: Exeliom Biosciences has raised $33.3M in total across 0 recorded funding rounds.